- Senior Investigator, OFFICE OF THE DIRECTOR
After receiving an M.P.H. in epidemiology from the University of North Carolina at Chapel Hill, Dr. Brinton joined the NCI as a staff fellow in 1976. She earned a Ph.D. in epidemiology from The Johns Hopkins School of Hygiene and Public Health in 1979, and subsequently conducted postdoctoral research at Oxford University in the United Kingdom. Dr. Brinton was appointed Acting Chief of the Environmental Studies Section in 1984, and in 1996 became Chief of the Environmental Epidemiology Branch (later called the Hormonal and Reproductive Epidemiology Branch). She served on the Executive Board of the Society for Epidemiologic Research, and was elected president of the organization in 1990. Dr. Brinton has received the PHS Special Recognition Award and the NIH Director's Award for innovative leadership in women's health research. She has also been honored by receipt of the H.A. Tyroler Distinguished Alumni Award from the University of North Carolina and the American College of Epidemiology’s Abraham Lilienfeld Award.
- (2012). A meta-analysis of genome-wide association studies of breast cancer identifies two novel susceptibility loci at 6q14 and 20q11. HUMAN MOLECULAR GENETICS. 21(24), 5373-5384.
- (2007). Genome-wide association study identifies novel breast cancer susceptibility loci. NATURE. 447(7148), 1087-U7.
- (2020). Reproductive factors and risk of breast cancer by tumor subtypes among Ghanaian women: A population-based case-control study. INTERNATIONAL JOURNAL OF CANCER. 147(6), 1535-1547.
- (2020). Prognostic gene expression signature for high-grade serous ovarian cancer. ANNALS OF ONCOLOGY. 31(9), 1240-1250.
- (2020). Mendelian randomization analyses suggest a role for cholesterol in the development of endometrial cancer. INTERNATIONAL JOURNAL OF CANCER.
- (2020). Association of Circulating Progesterone With Breast Cancer Risk Among Postmenopausal Women. JAMA Network Open. 3(4),
- (2020). Association of Anti-Mullerian Hormone, Follicle-Stimulating Hormone, and Inhibin B with Risk of Ovarian Cancer in the Janus Serum Bank. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION. 29(3), 636-642.
- (2020). The Risk of Ovarian Cancer Increases with an Increase in the Lifetime Number of Ovulatory Cycles: An Analysis from the Ovarian Cancer Cohort Consortium (OC3). CANCER RESEARCH. 80(5), 1210-1218.
- (2020). Endogenous estradiol and inflammation biomarkers: potential interacting mechanisms of obesity-related disease. CANCER CAUSES & CONTROL. 31(4), 309-320.